Christine Simmon
@csimmon_dc
President & CEO Food and Drug Law Institute (FDLI) , Thought-leader, Innovator
ID: 1019306932069285888
https://www.fdli.org/ 17-07-2018 19:44:45
198 Tweet
462 Takipçi
164 Takip Edilen
The negotiation framework in #BuildBackBetter undermines tremendous savings generated by the #biosimilars industry and constrains patient access in the process. The evidence is clear. Read our latest blog post from the Biosimilars Council to learn more: bit.ly/3EsZbrG